PRAME and cancer: As a novel diagnostic biomarker, an elevated PRAME expression level was correlated with more advanced malignant disease and a higher risk of metastasis, suggesting its pivotal role in cancer progression, including replicative immortality, invasion, and metastasis [155,156,157].